MersV1, PubMed, Corpus, bibRecord, 000573

Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.

Identifieur interne : 000573 ( PubMed/Corpus ); précédent : 000572; suivant : 000574

Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.

Auteurs : John H. Beigel ; Hannah H. Nam ; Peter L. Adams ; Amy Krafft ; William L. Ince ; Samer S. El-Kamary ; Amy C. Sims

Source :

Antiviral research [ 1872-9096 ] ; 2019.

RBID : pubmed:30974127

Abstract

The International Society for Influenza and other Respiratory Virus Diseases held its 6th Antiviral Group (isirv-AVG) conference in Rockville, Maryland, November 13-15, 2018. The three-day program was focused on therapeutics towards seasonal and pandemic influenza, respiratory syncytial virus, coronaviruses including MERS-CoV and SARS-CoV, human rhinovirus, and other respiratory viruses. Updates were presented on several influenza antivirals including baloxavir, CC-42344, VIS410, immunoglobulin, immune plasma, MHAA4549A, pimodivir (JNJ-63623872), umifenovir, and HA minibinders; RSV antivirals including presatovir (GS-5806), ziresovir (AK0529), lumicitabine (ALS-008176), JNJ-53718678, JNJ-64417184, and EDP-938; broad spectrum antivirals such as favipiravir, VH244, remdesivir, and EIDD-1931/EIDD-2801; and host directed strategies including nitazoxanide, eritoran, and diltiazem. Other topics included considerations of novel endpoints such as ordinal scales and patient reported outcomes (PRO), and study design issues, and other regulatory considerations for antiviral drug development. The aim of this report is to provide a summary of the presentations given at this meeting.

DOI: 10.1016/j.antiviral.2019.04.006
PubMed: 30974127

Links to Exploration step

pubmed:30974127

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.</title>
<author><name sortKey="Beigel, John H" sort="Beigel, John H" uniqKey="Beigel J" first="John H" last="Beigel">John H. Beigel</name>
<affiliation><nlm:affiliation>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: jbeigel@niaid.nih.gov.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Nam, Hannah H" sort="Nam, Hannah H" uniqKey="Nam H" first="Hannah H" last="Nam">Hannah H. Nam</name>
<affiliation><nlm:affiliation>(b)Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Adams, Peter L" sort="Adams, Peter L" uniqKey="Adams P" first="Peter L" last="Adams">Peter L. Adams</name>
<affiliation><nlm:affiliation>Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Krafft, Amy" sort="Krafft, Amy" uniqKey="Krafft A" first="Amy" last="Krafft">Amy Krafft</name>
<affiliation><nlm:affiliation>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ince, William L" sort="Ince, William L" uniqKey="Ince W" first="William L" last="Ince">William L. Ince</name>
<affiliation><nlm:affiliation>Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S Food and Drug Administration, Silver Spring, MD, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="El Kamary, Samer S" sort="El Kamary, Samer S" uniqKey="El Kamary S" first="Samer S" last="El-Kamary">Samer S. El-Kamary</name>
<affiliation><nlm:affiliation>Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S Food and Drug Administration, Silver Spring, MD, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sims, Amy C" sort="Sims, Amy C" uniqKey="Sims A" first="Amy C" last="Sims">Amy C. Sims</name>
<affiliation><nlm:affiliation>Gillings School of Global Public Health, Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:30974127</idno>
<idno type="pmid">30974127</idno>
<idno type="doi">10.1016/j.antiviral.2019.04.006</idno>
<idno type="wicri:Area/PubMed/Corpus">000573</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000573</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.</title>
<author><name sortKey="Beigel, John H" sort="Beigel, John H" uniqKey="Beigel J" first="John H" last="Beigel">John H. Beigel</name>
<affiliation><nlm:affiliation>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: jbeigel@niaid.nih.gov.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Nam, Hannah H" sort="Nam, Hannah H" uniqKey="Nam H" first="Hannah H" last="Nam">Hannah H. Nam</name>
<affiliation><nlm:affiliation>(b)Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Adams, Peter L" sort="Adams, Peter L" uniqKey="Adams P" first="Peter L" last="Adams">Peter L. Adams</name>
<affiliation><nlm:affiliation>Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Krafft, Amy" sort="Krafft, Amy" uniqKey="Krafft A" first="Amy" last="Krafft">Amy Krafft</name>
<affiliation><nlm:affiliation>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ince, William L" sort="Ince, William L" uniqKey="Ince W" first="William L" last="Ince">William L. Ince</name>
<affiliation><nlm:affiliation>Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S Food and Drug Administration, Silver Spring, MD, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="El Kamary, Samer S" sort="El Kamary, Samer S" uniqKey="El Kamary S" first="Samer S" last="El-Kamary">Samer S. El-Kamary</name>
<affiliation><nlm:affiliation>Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S Food and Drug Administration, Silver Spring, MD, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sims, Amy C" sort="Sims, Amy C" uniqKey="Sims A" first="Amy C" last="Sims">Amy C. Sims</name>
<affiliation><nlm:affiliation>Gillings School of Global Public Health, Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Antiviral research</title>
<idno type="eISSN">1872-9096</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The International Society for Influenza and other Respiratory Virus Diseases held its 6th Antiviral Group (isirv-AVG) conference in Rockville, Maryland, November 13-15, 2018. The three-day program was focused on therapeutics towards seasonal and pandemic influenza, respiratory syncytial virus, coronaviruses including MERS-CoV and SARS-CoV, human rhinovirus, and other respiratory viruses. Updates were presented on several influenza antivirals including baloxavir, CC-42344, VIS410, immunoglobulin, immune plasma, MHAA4549A, pimodivir (JNJ-63623872), umifenovir, and HA minibinders; RSV antivirals including presatovir (GS-5806), ziresovir (AK0529), lumicitabine (ALS-008176), JNJ-53718678, JNJ-64417184, and EDP-938; broad spectrum antivirals such as favipiravir, VH244, remdesivir, and EIDD-1931/EIDD-2801; and host directed strategies including nitazoxanide, eritoran, and diltiazem. Other topics included considerations of novel endpoints such as ordinal scales and patient reported outcomes (PRO), and study design issues, and other regulatory considerations for antiviral drug development. The aim of this report is to provide a summary of the presentations given at this meeting.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">30974127</PMID>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-9096</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>167</Volume>
<PubDate><Year>2019</Year>
<Month>07</Month>
</PubDate>
</JournalIssue>
<Title>Antiviral research</Title>
<ISOAbbreviation>Antiviral Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.</ArticleTitle>
<Pagination><MedlinePgn>45-67</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0166-3542(19)30158-5</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.antiviral.2019.04.006</ELocationID>
<Abstract><AbstractText>The International Society for Influenza and other Respiratory Virus Diseases held its 6th Antiviral Group (isirv-AVG) conference in Rockville, Maryland, November 13-15, 2018. The three-day program was focused on therapeutics towards seasonal and pandemic influenza, respiratory syncytial virus, coronaviruses including MERS-CoV and SARS-CoV, human rhinovirus, and other respiratory viruses. Updates were presented on several influenza antivirals including baloxavir, CC-42344, VIS410, immunoglobulin, immune plasma, MHAA4549A, pimodivir (JNJ-63623872), umifenovir, and HA minibinders; RSV antivirals including presatovir (GS-5806), ziresovir (AK0529), lumicitabine (ALS-008176), JNJ-53718678, JNJ-64417184, and EDP-938; broad spectrum antivirals such as favipiravir, VH244, remdesivir, and EIDD-1931/EIDD-2801; and host directed strategies including nitazoxanide, eritoran, and diltiazem. Other topics included considerations of novel endpoints such as ordinal scales and patient reported outcomes (PRO), and study design issues, and other regulatory considerations for antiviral drug development. The aim of this report is to provide a summary of the presentations given at this meeting.</AbstractText>
<CopyrightInformation>Published by Elsevier B.V.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beigel</LastName>
<ForeName>John H</ForeName>
<Initials>JH</Initials>
<AffiliationInfo><Affiliation>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: jbeigel@niaid.nih.gov.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Nam</LastName>
<ForeName>Hannah H</ForeName>
<Initials>HH</Initials>
<AffiliationInfo><Affiliation>(b)Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Adams</LastName>
<ForeName>Peter L</ForeName>
<Initials>PL</Initials>
<AffiliationInfo><Affiliation>Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Krafft</LastName>
<ForeName>Amy</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ince</LastName>
<ForeName>William L</ForeName>
<Initials>WL</Initials>
<AffiliationInfo><Affiliation>Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S Food and Drug Administration, Silver Spring, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>El-Kamary</LastName>
<ForeName>Samer S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo><Affiliation>Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S Food and Drug Administration, Silver Spring, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sims</LastName>
<ForeName>Amy C</ForeName>
<Initials>AC</Initials>
<AffiliationInfo><Affiliation>Gillings School of Global Public Health, Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2019</Year>
<Month>04</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Antiviral Res</MedlineTA>
<NlmUniqueID>8109699</NlmUniqueID>
<ISSNLinking>0166-3542</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Antiviral therapy</Keyword>
<Keyword MajorTopicYN="Y">Coronavirus</Keyword>
<Keyword MajorTopicYN="Y">Host-directed therapeutics</Keyword>
<Keyword MajorTopicYN="Y">Influenza</Keyword>
<Keyword MajorTopicYN="Y">Respiratory syncytial virus</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year>
<Month>03</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2019</Year>
<Month>04</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2019</Year>
<Month>4</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>4</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2019</Year>
<Month>4</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">30974127</ArticleId>
<ArticleId IdType="pii">S0166-3542(19)30158-5</ArticleId>
<ArticleId IdType="doi">10.1016/j.antiviral.2019.04.006</ArticleId>
<ArticleId IdType="pmc">PMC7132446</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Sci Rep. 2017 Mar 06;7:43395</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28262699</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Microbiol. 2005 May;43(5):2356-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15872266</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Transpl Infect Dis. 2016 Apr;18(2):210-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26923867</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Front Microbiol. 2018 Dec 06;9:3026</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30574137</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2014 Jan;58(2):214-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24186906</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Influenza Other Respir Viruses. 2017 Nov;11(6):525-530</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28990339</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2008 Sep;82(17):8721-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18579604</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet Infect Dis. 2018 Apr;18(4):410-418</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29329957</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2014 Jul;107:84-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24769245</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Sci Transl Med. 2016 Feb 17;8(326):326ra21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26888429</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS One. 2012;7(1):e29652</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22276122</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2015 Nov 19;373(21):2048-58</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26580997</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Obstet Gynecol. 2011 Jun;204(6):524.e1-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21457910</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Value Health. 2018 Feb;21(2):210-218</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29477403</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2018 Jul 27;62(8):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29891600</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2011 Feb 15;52(4):447-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21248066</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2018 Mar 13;9(2):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29535197</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell Physiol Biochem. 2018;51(5):2377-2396</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30537741</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Virol. 2010 Jan;47(1):23-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19962344</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2017 Aug;144:48-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28535933</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>MAbs. 2016 Jul;8(5):991-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27031797</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>HIV Med. 2016 Jan;17(1):28-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26200570</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2018 Jul 24;218(5):748-756</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29684148</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2013 Oct;87(19):10524-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23824822</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Influenza Other Respir Viruses. 2018 Mar;12(2):267-278</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29265727</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2013 May 23;497(7450):498-502</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23636320</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2017 Oct 5;550(7674):74-79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28953867</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2017 Oct 24;61(11):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28807912</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2015 Dec 15;212(12):1904-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26198719</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Sci Rep. 2018 Jun 25;8(1):9633</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29941893</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Sci Transl Med. 2017 Jun 28;9(396):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28659436</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Front Immunol. 2019 Jan 29;10:60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30761132</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2016 Aug 22;60(9):5504-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27381402</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>JCI Insight. 2018 Dec 20;3(24):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30568032</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2013 Oct;19(10):1313-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24013700</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Trials. 2018 Jan 30;19(1):81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29382391</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):10890-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26283346</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Trials. 2017 Jun;14(3):264-276</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28397569</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Springerplus. 2015 Nov 19;4:709</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26618098</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Thorax. 2004 Mar;59(3):252-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14985565</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2009 Apr 16;458(7240):914-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19194459</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Ann Intern Med. 2006 Oct 17;145(8):599-609</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16940336</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Chem. 2017 Mar 9;60(5):1648-1661</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28124907</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMC Anesthesiol. 2016 Jul 12;16(1):36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27405596</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2013 Aug;94(Pt 8):1749-1760</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23620378</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antivir Ther. 2018;23(4):335-344</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29244026</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Drugs. 2010 Oct 1;70(14):1885-915</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20836579</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Chest. 2013 Aug;144(2):464-473</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23450336</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19944-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19036930</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS One. 2018 Nov 15;13(11):e0206831</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30439974</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2017 Apr 4;8(2):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28377531</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Expert Opin Investig Drugs. 2017 Jan;26(1):63-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27918208</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet Respir Med. 2017 Feb;5(2):135-146</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28094141</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2010 Jun 1;201(11):1654-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20423224</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2015 Dec 14;60(3):1264-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26666922</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2019 Nov 13;69(11):1903-1911</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30753384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Int J Infect Dis. 2014 Mar;20:42-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24406736</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2005 Oct 1;366(9492):1175-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16198766</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Ther. 2018 Aug;40(8):1268-1281</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30077340</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet Infect Dis. 2014 Jul;14(7):609-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24852376</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2005 Jun 1;191(11):1861-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15871119</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2014 Mar;95(Pt 3):571-577</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24323636</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Chest. 2017 May;151(5):1069-1080</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27884765</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2018 Jan;149:118-142</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29162476</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2018 Mar 6;9(2):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29511076</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2017 Feb 9;376(6):584-594</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28177862</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2017 Sep 2;390(10098):946-958</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28689664</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2018 Nov 2;362(6414):598-602</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30385580</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2014 Jun 15;209(12):1873-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24482398</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Microbiol. 2016 Nov 28;2:16226</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27892925</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 2008 Apr 15;180(8):5662-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18390751</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Expert Opin Biol Ther. 2018 Jun;18(6):665-680</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29624084</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26976607</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2013 Nov;100(2):446-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24084488</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2017 Aug 24;61(9):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28652242</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2016 Mar 17;531(7594):381-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26934220</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):206-214</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28003465</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect. 2013 Dec;67(6):606-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24096239</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2019 Mar 15;219(7):1026-1034</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30428049</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2015 May 2;385(9979):1729-1737</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25640810</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Sci Rep. 2017 Aug 4;7(1):7345</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28779075</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Br J Clin Pharmacol. 1996 Dec;42(6):697-705</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8971424</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell Rep. 2015 Jun 30;11(12):1941-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26095366</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet Infect Dis. 2018 Nov;18(11):1191-1210</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30243584</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2018 Dec;160:109-117</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30316915</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMC Infect Dis. 2016 Apr 21;16:174</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27097824</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Drug Discov Technol. 2018;15(3):201-213</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28748751</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2011 Oct 1;204(7):996-1002</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21881113</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24841269</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2008 Apr;82(7):3220-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18199635</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 1990 Apr;161(4):640-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2319164</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2015 Mar;59(3):1569-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25547360</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Sci Rep. 2018 Jul 11;8(1):10425</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29992955</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2014 Oct;110:94-103</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25108173</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2008 Sep;82(17):8570-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18579602</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2014 Aug 21;371(8):711-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25140957</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2015 Dec;21(12):1508-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26552008</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Int J Infect Dis. 2016 Feb;43:77-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26775570</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2018 Apr 24;9(2):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29691337</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2009 Apr 17;58(14):369-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19373198</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S84-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21492826</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Chem. 2017 May 11;60(9):3533-3551</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28118010</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet Respir Med. 2017 Jun;5(6):500-511</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28522352</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Crit Care Med. 2014 Feb;42(2):313-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24105455</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Antimicrob Chemother. 2019 Mar 1;74(3):654-662</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30476172</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2005 Apr 28;352(17):1749-59</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15858184</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2018 Feb;150:202-216</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29325970</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS One. 2014 Nov 21;9(11):e113100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25415360</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2007 Jul;81(14):7410-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17507479</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2018 Sep 6;379(10):913-923</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30184455</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Health Qual Life Outcomes. 2006 Oct 11;4:79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17034633</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Euro Surveill. 2019 Jan;24(3):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30670144</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2017 Oct;146:12-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28802866</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2014 Dec 15;59(12):e172-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25115871</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Can Respir J. 2018 Jun 19;2018:2732017</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30018677</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2018 Mar 19;66(7):1042-1044</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29088341</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2011 May 13;332(6031):816-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21566186</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2009 Dec 15;49(12):1828-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19911968</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Microbiol. 2003 Feb;41(2):742-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12574276</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Eur J Med Chem. 2017 Jan 27;126:154-159</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27750149</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Sci Rep. 2017 Jan 20;7:40791</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28106157</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2009 Feb 5;360(6):588-98</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19196675</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29161116</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>EBioMedicine. 2019 Feb;40:574-582</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30638863</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Respir Crit Care Med. 2010 Nov 15;182(10):1305-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20622030</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet Infect Dis. 2014 Nov;14(11):1090-1095</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25278221</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2008 Mar;82(5):2274-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18094188</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000573 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000573 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:30974127
   |texte=   Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:30974127" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021

	Serveur d'exploration MERS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration MERS

Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.

Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki